Published in Drug Week, January 7th, 2005
Life Science Insights expects CROs to increase their spending on IT at a compound annual growth rate (CAGR) of 6.4% over the 2003-2008 period, reaching $1.7 billion by 2008.
"Today, clinical trial sponsors are selecting CROs with the technological capabilities that enable them to increase efficiency, time to market, and provide earlier risk evaluation during the clinical trial phase," said Ellen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.